AC Bioscience AC Bioscience
  • Our Company
  • About us
    • About us
    • Leadership
    • Scientific and Clinical Advisory Board
  • Strategy
    • Strategy
    • Innovative Approach
    • R&D Priorities
    • Business Model
    • Intellectual Property
    • Partnerships
  • Pipeline
    • Pipeline
    • Sphingosine-1-phosphate (S.1.p)
    • Beta-carboline derivate (ACB1801)
    • Cationic amphipathic peptide (CAP)
    • Validation Stages and Timelines
  • News
  • Publications
  • Contact

 

Publications

 

 

ACBS CHIMIA 2020 3 thumb

Is Sphingosine-1-Phosphate a Regulator of Tumor Vascular Functionality?
Cancers, 03 March 2022

ACBS CHIMIA 2020 3 thumb

MHC-1 Mediated Antigen Presentation Machinery as a Key of Tumor Cells Immune Escape Control
Journal of immunology sciences, 08 February 2021

ACBS CHIMIA 2020 3 thumb

The "Holy Grail" in Immuno-Oncology : AC BioScience SA is Aiming to Potentiate Anti-PD-1 Therapy Efficacy through Tumor Cell Conditioning Strategy
Chimia, October 2020

ACBS CHIMIA 2020 3 thumb

The β-carboline Harmine Induces Actin Dynamic Remodeling and Abrogates the Malignant Phenotype in Tumorigenic Cells
Cells, 8 May 2020

 

AC Bioscience

Copyright © 2022 AC BioScience SA. All Rights Reserved.

logo white

AC BioScience SA  |  Biopôle  |  Route de la Corniche 4 - Lysine  |  CH-1066 Epalinges  |  info@ac-bioscience.com